A Pilot Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer
Latest Information Update: 12 Mar 2025
At a glance
- Drugs NP 137 (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Adenocarcinoma; Pancreatic cancer; Pancreatic ductal carcinoma
- Focus Therapeutic Use
Most Recent Events
- 10 Mar 2025 Planned initiation date changed from 1 Jan 2025 to 1 Sep 2025.
- 10 Jul 2024 Planned initiation date changed from 1 Jul 2024 to 1 Jan 2025.
- 16 Jan 2024 New trial record